Literature DB >> 14517717

A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis.

W Huang1, M H Drissi, R J O'Keefe, E M Schwarz.   

Abstract

Macrophages differentiate into osteoclasts in response to the critical cytokine RANKL. However, the efficiency of RANKL-mediated osteoclastogenesis can be profoundly influenced by various cytokines. While studies describing the isolated effects of particular cytokines on osteoclastogenesis have been performed, combinatorial effects of cytokines have not been addressed routinely due to the absence of an efficient assay system. To study the effects of cytokine combinations on osteoclast formation, we performed in vitro assays using either the RAW293 cell line or primary murine splenic macrophages as osteoclast precursors. Using a multiparameter cytokine plating method, we analyzed osteoclastogenesis in response to multiple combinations of the following inflammation-related cytokines: RANKL, IFN-gamma, TNF-alpha, IL-1beta, IL-6, IL-10. We further investigated the role of T-cell-related cytokine combinations on osteoclastogenesis by measuring osteoclast area in response to RANKL with IFN-gamma, IL-2, IL-4, IL-6, TGF-ss, and TNF-alpha. Treatments with RANKL, TNF-alpha, and TGF-ss induced maximal osteoclast formation, suggesting a role for these cytokines in the most aggressive forms of inflammatory bone loss. TNF-alpha alone, however, was unable to induce osteoclast formation in the absence of RANKL despite co-administration of other proinflammatory cytokines. IFN-gamma was a potent inhibitor under all conditions, implicating T cells and NK cells in osteoclast inhibition. These studies demonstrate a rapid screening approach for identifying the potential collective effects of multiple factors on osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517717     DOI: 10.1007/s00223-003-0059-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  7 in total

1.  Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litivn
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation.

Authors:  Michael Darowish; Ra'Kerry Rahman; Ping Li; Susan V Bukata; Jill Gelinas; Willis Huang; Lisa M Flick; Edward M Schwarz; Regis J O'Keefe
Journal:  Bone       Date:  2009-06-12       Impact factor: 4.398

3.  The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.

Authors:  Janja Zupan; Radko Komadina; Janja Marc
Journal:  J Biomed Sci       Date:  2012-03-01       Impact factor: 8.410

Review 4.  Cytokine-mediated bone destruction in rheumatoid arthritis.

Authors:  Seung Min Jung; Kyoung Woon Kim; Chul-Woo Yang; Sung-Hwan Park; Ji Hyeon Ju
Journal:  J Immunol Res       Date:  2014-09-10       Impact factor: 4.818

5.  Staphylococcal protein A promotes osteoclastogenesis through MAPK signaling during bone infection.

Authors:  Yuan Wang; Xin Liu; Ce Dou; Zhen Cao; Chuan Liu; Shiwu Dong; Jun Fei
Journal:  J Cell Physiol       Date:  2017-03-31       Impact factor: 6.384

Review 6.  Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts.

Authors:  Janja Zupan; Matjaz Jeras; Janja Marc
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

7.  Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis.

Authors:  Yasunori Omata; Shinya Nakamura; Takuma Koyama; Tetsuro Yasui; Jun Hirose; Naohiro Izawa; Takumi Matsumoto; Yuuki Imai; Sachiko Seo; Mineo Kurokawa; Shuichi Tsutsumi; Yuho Kadono; Chikao Morimoto; Hiroyuki Aburatani; Takeshi Miyamoto; Sakae Tanaka
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.